APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tumor Treatment Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Tumor Treatment Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026199 pages

Choose your research edition.

Industry ResearchTumor Treatment Drug Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Tumor Treatment Drug Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Tumor Treatment Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tumor Treatment Drug Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Tumor Treatment Drug Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Tumor Treatment Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Tumor Treatment Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tumor Treatment Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tumor Treatment Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Tumor Treatment Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tumor Treatment Drug include Astellas, Biogen Idec, Bristol-Myers Squibb, Celgene, Gilead Sciences, Ipsen, Merck & Co., Otsuka and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Tumor Treatment Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tumor Treatment Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tumor Treatment Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Tumor Treatment Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Tumor Treatment Drug Segment by Company

Astellas

Biogen Idec

Bristol-Myers Squibb

Celgene

Gilead Sciences

Ipsen

Merck & Co.

Otsuka

AstraZeneca

AbbVie

Amgen

Bayer

Pfizer

Eli Lilly

Roche

Merck KGaA

Novartis

Johnson & Johnson

Sanofi

Teva

Eisai

Takeda

Tumor Treatment Drug Segment by Type

Immunotherapy (Biologic Therapy)

Chemotherapy

Hormonal Therapy

Targeted Therapy

Others

Tumor Treatment Drug Segment by Application

Respiratory/Lung Cancer

Prostate Cancer

Breast Cancer

Gastrointestinal Cancer

Blood Cancer

Others

Tumor Treatment Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Treatment Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tumor Treatment Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Treatment Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Tumor Treatment Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tumor Treatment Drug industry.

Chapter 3: Detailed analysis of Tumor Treatment Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tumor Treatment Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Tumor Treatment Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Immunotherapy (Biologic Therapy) Table 3. Key Players of Chemotherapy Table 4. Key Players of Hormonal Therapy Table 3. Key Players of Targeted Therapy Table 4. Key Players of Others Table 5. Global Tumor Treatment Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Respiratory/Lung Cancer Table 7. Key Players of Prostate Cancer Table 8. Key Players of Breast Cancer Table 9. Key Players of Gastrointestinal Cancer Table 10. Key Players of Blood Cancer Table 11. Key Players of Others Table 12. Global Tumor Treatment Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Tumor Treatment Drug Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Tumor Treatment Drug Market Share by Region (2021-2026) Table 15. Global Tumor Treatment Drug Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Tumor Treatment Drug Market Share by Region (2027-2032) Table 17. Tumor Treatment Drug Industry Trends Table 18. Tumor Treatment Drug Industry Drivers Table 19. Tumor Treatment Drug Industry Opportunities and Challenges Table 20. Tumor Treatment Drug Industry Restraints Table 21. Global Tumor Treatment Drug Revenue by Company (US$ Million) & (2021-2026) Table 22. Global Tumor Treatment Drug Revenue Market Share by Company (2021-2026) Table 23. Global Tumor Treatment Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 24. Global Tumor Treatment Drug Key Company Head Office and Area Served Table 25. Global Tumor Treatment Drug Company, Product Type & Application Table 26. Global Tumor Treatment Drug Company Establishment Date Table 27. Global Company Market Concentration Ratio (CR5 and HHI) Table 28. Global Tumor Treatment Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 29. Global Tumor Treatment Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Tumor Treatment Drug Market Size by Type (2021-2026) & (US$ Million) Table 31. Global Tumor Treatment Drug Market Size by Type (2027-2032) & (US$ Million) Table 32. Global Tumor Treatment Drug Revenue Market Share by Type (2021-2026) Table 33. Global Tumor Treatment Drug Revenue Market Share by Type (2027-2032) Table 34. Global Tumor Treatment Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Tumor Treatment Drug Market Size by Application (2021-2026) & (US$ Million) Table 36. Global Tumor Treatment Drug Market Size by Application (2027-2032) & (US$ Million) Table 37. Global Tumor Treatment Drug Revenue Market Share by Application (2021-2026) Table 38. Global Tumor Treatment Drug Revenue Market Share by Application (2027-2032) Table 39. Astellas Company Information Table 40. Astellas Business Overview Table 41. Astellas Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Astellas Tumor Treatment Drug Product Portfolio Table 43. Astellas Recent Development Table 44. Biogen Idec Company Information Table 45. Biogen Idec Business Overview Table 46. Biogen Idec Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Biogen Idec Tumor Treatment Drug Product Portfolio Table 48. Biogen Idec Recent Development Table 49. Bristol-Myers Squibb Company Information Table 50. Bristol-Myers Squibb Business Overview Table 51. Bristol-Myers Squibb Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Bristol-Myers Squibb Tumor Treatment Drug Product Portfolio Table 53. Bristol-Myers Squibb Recent Development Table 54. Celgene Company Information Table 55. Celgene Business Overview Table 56. Celgene Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Celgene Tumor Treatment Drug Product Portfolio Table 58. Celgene Recent Development Table 59. Gilead Sciences Company Information Table 60. Gilead Sciences Business Overview Table 61. Gilead Sciences Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Gilead Sciences Tumor Treatment Drug Product Portfolio Table 63. Gilead Sciences Recent Development Table 64. Ipsen Company Information Table 65. Ipsen Business Overview Table 66. Ipsen Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Ipsen Tumor Treatment Drug Product Portfolio Table 68. Ipsen Recent Development Table 69. Merck & Co. Company Information Table 70. Merck & Co. Business Overview Table 71. Merck & Co. Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Merck & Co. Tumor Treatment Drug Product Portfolio Table 73. Merck & Co. Recent Development Table 74. Otsuka Company Information Table 75. Otsuka Business Overview Table 76. Otsuka Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Otsuka Tumor Treatment Drug Product Portfolio Table 78. Otsuka Recent Development Table 79. AstraZeneca Company Information Table 80. AstraZeneca Business Overview Table 81. AstraZeneca Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. AstraZeneca Tumor Treatment Drug Product Portfolio Table 83. AstraZeneca Recent Development Table 84. AbbVie Company Information Table 85. AbbVie Business Overview Table 86. AbbVie Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. AbbVie Tumor Treatment Drug Product Portfolio Table 88. AbbVie Recent Development Table 89. Amgen Company Information Table 90. Amgen Business Overview Table 91. Amgen Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Amgen Tumor Treatment Drug Product Portfolio Table 93. Amgen Recent Development Table 94. Bayer Company Information Table 95. Bayer Business Overview Table 96. Bayer Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Bayer Tumor Treatment Drug Product Portfolio Table 98. Bayer Recent Development Table 99. Pfizer Company Information Table 100. Pfizer Business Overview Table 101. Pfizer Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. Pfizer Tumor Treatment Drug Product Portfolio Table 103. Pfizer Recent Development Table 104. Eli Lilly Company Information Table 105. Eli Lilly Business Overview Table 106. Eli Lilly Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. Eli Lilly Tumor Treatment Drug Product Portfolio Table 108. Eli Lilly Recent Development Table 109. Roche Company Information Table 110. Roche Business Overview Table 111. Roche Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. Roche Tumor Treatment Drug Product Portfolio Table 113. Roche Recent Development Table 114. Merck KGaA Company Information Table 115. Merck KGaA Business Overview Table 116. Merck KGaA Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 117. Merck KGaA Tumor Treatment Drug Product Portfolio Table 118. Merck KGaA Recent Development Table 119. Novartis Company Information Table 120. Novartis Business Overview Table 121. Novartis Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 122. Novartis Tumor Treatment Drug Product Portfolio Table 123. Novartis Recent Development Table 124. Johnson & Johnson Company Information Table 125. Johnson & Johnson Business Overview Table 126. Johnson & Johnson Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 127. Johnson & Johnson Tumor Treatment Drug Product Portfolio Table 128. Johnson & Johnson Recent Development Table 129. Sanofi Company Information Table 130. Sanofi Business Overview Table 131. Sanofi Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 132. Sanofi Tumor Treatment Drug Product Portfolio Table 133. Sanofi Recent Development Table 134. Teva Company Information Table 135. Teva Business Overview Table 136. Teva Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 137. Teva Tumor Treatment Drug Product Portfolio Table 138. Teva Recent Development Table 139. Eisai Company Information Table 140. Eisai Business Overview Table 141. Eisai Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 142. Eisai Tumor Treatment Drug Product Portfolio Table 143. Eisai Recent Development Table 144. Takeda Company Information Table 145. Takeda Business Overview Table 146. Takeda Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 147. Takeda Tumor Treatment Drug Product Portfolio Table 148. Takeda Recent Development Table 149. North America Tumor Treatment Drug Market Size by Type (2021-2026) & (US$ Million) Table 150. North America Tumor Treatment Drug Market Size by Type (2027-2032) & (US$ Million) Table 151. North America Tumor Treatment Drug Market Size by Application (2021-2026) & (US$ Million) Table 152. North America Tumor Treatment Drug Market Size by Application (2027-2032) & (US$ Million) Table 153. North America Tumor Treatment Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. North America Tumor Treatment Drug Market Size by Country (2021-2026) Table 155. North America Tumor Treatment Drug Market Size by Country (2027-2032) Table 156. Europe Tumor Treatment Drug Market Size by Type (2021-2026) & (US$ Million) Table 157. Europe Tumor Treatment Drug Market Size by Type (2027-2032) & (US$ Million) Table 158. Europe Tumor Treatment Drug Market Size by Application (2021-2026) & (US$ Million) Table 159. Europe Tumor Treatment Drug Market Size by Application (2027-2032) & (US$ Million) Table 160. Europe Tumor Treatment Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. Europe Tumor Treatment Drug Market Size by Country (2021-2026) Table 162. Europe Tumor Treatment Drug Market Size by Country (2027-2032) Table 163. China Tumor Treatment Drug Market Size by Type (2021-2026) & (US$ Million) Table 164. China Tumor Treatment Drug Market Size by Type (2027-2032) & (US$ Million) Table 165. China Tumor Treatment Drug Market Size by Application (2021-2026) & (US$ Million) Table 166. China Tumor Treatment Drug Market Size by Application (2027-2032) & (US$ Million) Table 167. Asia Tumor Treatment Drug Market Size by Type (2021-2026) & (US$ Million) Table 168. Asia Tumor Treatment Drug Market Size by Type (2027-2032) & (US$ Million) Table 169. Asia Tumor Treatment Drug Market Size by Application (2021-2026) & (US$ Million) Table 170. Asia Tumor Treatment Drug Market Size by Application (2027-2032) & (US$ Million) Table 171. Asia Tumor Treatment Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. Asia Tumor Treatment Drug Market Size by Country (2021-2026) Table 173. Asia Tumor Treatment Drug Market Size by Country (2027-2032) Table 174. South America, Middle East & Africa Tumor Treatment Drug Market Size by Type (2021-2026) & (US$ Million) Table 175. South America, Middle East & Africa Tumor Treatment Drug Market Size by Type (2027-2032) & (US$ Million) Table 176. South America, Middle East & Africa Tumor Treatment Drug Market Size by Application (2021-2026) & (US$ Million) Table 177. South America, Middle East & Africa Tumor Treatment Drug Market Size by Application (2027-2032) & (US$ Million) Table 178. South America, Middle East & Africa Tumor Treatment Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. South America, Middle East & Africa Tumor Treatment Drug Market Size by Country (2021-2026) Table 180. South America, Middle East & Africa Tumor Treatment Drug Market Size by Country (2027-2032) Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Tumor Treatment Drug Product Image Figure 2. Global Tumor Treatment Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Tumor Treatment Drug Market Share by Type: 2025 VS 2032 Figure 4. Immunotherapy (Biologic Therapy) Image Figure 5. Chemotherapy Image Figure 6. Hormonal Therapy Image Figure 7. Targeted Therapy Image Figure 8. Others Image Figure 9. Global Tumor Treatment Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Tumor Treatment Drug Market Share by Application: 2025 VS 2032 Figure 11. Respiratory/Lung Cancer Image Figure 12. Prostate Cancer Image Figure 13. Breast Cancer Image Figure 14. Gastrointestinal Cancer Image Figure 15. Blood Cancer Image Figure 16. Others Image Figure 17. Global Tumor Treatment Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 19. Global Tumor Treatment Drug Market Share by Region: 2025 VS 2032 Figure 20. Years Considered Figure 21. Global Tumor Treatment Drug Market Share by Players in 2025 Figure 22. Global Top 5 and 10 Tumor Treatment Drug Players Market Share by Revenue in 2025 Figure 23. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. Global Tumor Treatment Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Tumor Treatment Drug Revenue Market Share by Type (2021-2032) Figure 26. Global Tumor Treatment Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Tumor Treatment Drug Revenue Market Share by Application (2021-2032) Figure 28. North America Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 29. North America Tumor Treatment Drug Market Share by Type (2021-2032) Figure 30. North America Tumor Treatment Drug Market Share by Application (2021-2032) Figure 31. North America Tumor Treatment Drug Market Share by Country (2021-2032) Figure 32. United States Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 33. Canada Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 34. Mexico Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 35. Europe Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 36. Europe Tumor Treatment Drug Market Share by Type (2021-2032) Figure 37. Europe Tumor Treatment Drug Market Share by Application (2021-2032) Figure 38. Europe Tumor Treatment Drug Market Share by Country (2021-2032) Figure 39. Germany Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 40. France Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 41. U.K. Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 42. Italy Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 43. Russia Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 44. Nordic Countries Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 45. China Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 46. China Tumor Treatment Drug Market Share by Type (2021-2032) Figure 47. China Tumor Treatment Drug Market Share by Application (2021-2032) Figure 48. Asia Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 49. Asia Tumor Treatment Drug Market Share by Type (2021-2032) Figure 50. Asia Tumor Treatment Drug Market Share by Application (2021-2032) Figure 51. Asia Tumor Treatment Drug Market Share by Country (2021-2032) Figure 52. Japan Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 53. South Korea Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 54. Taiwan Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 55. Southeast Asia Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 56. India Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 57. Australia Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 59. South America, Middle East & Africa Tumor Treatment Drug Market Share by Type (2021-2032) Figure 60. South America, Middle East & Africa Tumor Treatment Drug Market Share by Application (2021-2032) Figure 61. South America, Middle East & Africa Tumor Treatment Drug Market Share by Country (2021-2032) Figure 62. Brazil Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 63. South Africa Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 64. Saudi Arabia Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 65. Turkey Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 66. Argentina Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 67. UAE Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 68. Egypt Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 69. Chile Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Immunotherapy (Biologic Therapy)
  • Chemotherapy
  • Hormonal Therapy
  • Targeted Therapy
  • Others
Applications
  • Respiratory/Lung Cancer
  • Prostate Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Blood Cancer
  • Others
Companies covered
  • Astellas
  • Biogen Idec
  • Bristol-Myers Squibb
  • Celgene
  • Gilead Sciences
  • Ipsen
  • Merck & Co.
  • Otsuka
  • AstraZeneca
  • AbbVie
  • Amgen
  • Bayer
  • Pfizer
  • Eli Lilly
  • Roche
  • Merck KGaA
  • Novartis
  • Johnson & Johnson
  • Sanofi
  • Teva
  • Eisai
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Tumor Treatment Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Immunotherapy (Biologic Therapy)
  5. 1.2.3 Chemotherapy
  6. 1.2.4 Hormonal Therapy
  7. 1.2.5 Targeted Therapy
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Tumor Treatment Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Respiratory/Lung Cancer
  12. 1.3.3 Prostate Cancer
  13. 1.3.4 Breast Cancer
  14. 1.3.5 Gastrointestinal Cancer
  15. 1.3.6 Blood Cancer
  16. 1.3.7 Others
  17. 1.4 Global Market Growth Prospects
  18. 1.5 Global Tumor Treatment Drug Growth Trends by Region
  19. 1.5.1 Global Tumor Treatment Drug Market Size by Region: 2021 VS 2025 VS 2032
  20. 1.5.2 Tumor Treatment Drug Market Size by Region (2021-2026)
  21. 1.5.3 Tumor Treatment Drug Market Size by Region (2027-2032)
  22. 1.6 Assumptions and Limitations
  23. 1.7 Study Goals and Objectives
  24. 1.8 Years Considered
2 Global Tumor Treatment Drug Market Dynamics
  1. 2.1 Tumor Treatment Drug Industry Trends
  2. 2.2 Tumor Treatment Drug Industry Drivers
  3. 2.3 Tumor Treatment Drug Industry Opportunities and Challenges
  4. 2.4 Tumor Treatment Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Tumor Treatment Drug Revenue by Company (2021-2026)
  2. 3.2 Global Tumor Treatment Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Tumor Treatment Drug Key Company Head office and Area Served
  4. 3.4 Global Tumor Treatment Drug Company, Product Type & Application
  5. 3.5 Global Tumor Treatment Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Tumor Treatment Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Tumor Treatment Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Tumor Treatment Drug Tier 1, Tier 2, and Tier 3
4 Tumor Treatment Drug Market by Type
  1. 4.1 Global Tumor Treatment Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Tumor Treatment Drug Market Size by Type (2021-2032)
  3. 4.3 Global Tumor Treatment Drug Market Size Share by Type (2021-2032)
5 Tumor Treatment Drug Market by Application
  1. 5.1 Global Tumor Treatment Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Tumor Treatment Drug Market Size by Application (2021-2032)
  3. 5.3 Global Tumor Treatment Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Astellas
  2. 6.1.1 Astellas Company Information
  3. 6.1.2 Astellas Business Overview
  4. 6.1.3 Astellas Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Astellas Tumor Treatment Drug Product Portfolio
  6. 6.1.5 Astellas Recent Developments
  7. 6.2 Biogen Idec
  8. 6.2.1 Biogen Idec Company Information
  9. 6.2.2 Biogen Idec Business Overview
  10. 6.2.3 Biogen Idec Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Biogen Idec Tumor Treatment Drug Product Portfolio
  12. 6.2.5 Biogen Idec Recent Developments
  13. 6.3 Bristol-Myers Squibb
  14. 6.3.1 Bristol-Myers Squibb Company Information
  15. 6.3.2 Bristol-Myers Squibb Business Overview
  16. 6.3.3 Bristol-Myers Squibb Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Bristol-Myers Squibb Tumor Treatment Drug Product Portfolio
  18. 6.3.5 Bristol-Myers Squibb Recent Developments
  19. 6.4 Celgene
  20. 6.4.1 Celgene Company Information
  21. 6.4.2 Celgene Business Overview
  22. 6.4.3 Celgene Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Celgene Tumor Treatment Drug Product Portfolio
  24. 6.4.5 Celgene Recent Developments
  25. 6.5 Gilead Sciences
  26. 6.5.1 Gilead Sciences Company Information
  27. 6.5.2 Gilead Sciences Business Overview
  28. 6.5.3 Gilead Sciences Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Gilead Sciences Tumor Treatment Drug Product Portfolio
  30. 6.5.5 Gilead Sciences Recent Developments
  31. 6.6 Ipsen
  32. 6.6.1 Ipsen Company Information
  33. 6.6.2 Ipsen Business Overview
  34. 6.6.3 Ipsen Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Ipsen Tumor Treatment Drug Product Portfolio
  36. 6.6.5 Ipsen Recent Developments
  37. 6.7 Merck & Co.
  38. 6.7.1 Merck & Co. Company Information
  39. 6.7.2 Merck & Co. Business Overview
  40. 6.7.3 Merck & Co. Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Merck & Co. Tumor Treatment Drug Product Portfolio
  42. 6.7.5 Merck & Co. Recent Developments
  43. 6.8 Otsuka
  44. 6.8.1 Otsuka Company Information
  45. 6.8.2 Otsuka Business Overview
  46. 6.8.3 Otsuka Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Otsuka Tumor Treatment Drug Product Portfolio
  48. 6.8.5 Otsuka Recent Developments
  49. 6.9 AstraZeneca
  50. 6.9.1 AstraZeneca Company Information
  51. 6.9.2 AstraZeneca Business Overview
  52. 6.9.3 AstraZeneca Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 AstraZeneca Tumor Treatment Drug Product Portfolio
  54. 6.9.5 AstraZeneca Recent Developments
  55. 6.10 AbbVie
  56. 6.10.1 AbbVie Company Information
  57. 6.10.2 AbbVie Business Overview
  58. 6.10.3 AbbVie Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 AbbVie Tumor Treatment Drug Product Portfolio
  60. 6.10.5 AbbVie Recent Developments
  61. 6.11 Amgen
  62. 6.11.1 Amgen Company Information
  63. 6.11.2 Amgen Business Overview
  64. 6.11.3 Amgen Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Amgen Tumor Treatment Drug Product Portfolio
  66. 6.11.5 Amgen Recent Developments
  67. 6.12 Bayer
  68. 6.12.1 Bayer Company Information
  69. 6.12.2 Bayer Business Overview
  70. 6.12.3 Bayer Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Bayer Tumor Treatment Drug Product Portfolio
  72. 6.12.5 Bayer Recent Developments
  73. 6.13 Pfizer
  74. 6.13.1 Pfizer Company Information
  75. 6.13.2 Pfizer Business Overview
  76. 6.13.3 Pfizer Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Pfizer Tumor Treatment Drug Product Portfolio
  78. 6.13.5 Pfizer Recent Developments
  79. 6.14 Eli Lilly
  80. 6.14.1 Eli Lilly Company Information
  81. 6.14.2 Eli Lilly Business Overview
  82. 6.14.3 Eli Lilly Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Eli Lilly Tumor Treatment Drug Product Portfolio
  84. 6.14.5 Eli Lilly Recent Developments
  85. 6.15 Roche
  86. 6.15.1 Roche Company Information
  87. 6.15.2 Roche Business Overview
  88. 6.15.3 Roche Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Roche Tumor Treatment Drug Product Portfolio
  90. 6.15.5 Roche Recent Developments
  91. 6.16 Merck KGaA
  92. 6.16.1 Merck KGaA Company Information
  93. 6.16.2 Merck KGaA Business Overview
  94. 6.16.3 Merck KGaA Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Merck KGaA Tumor Treatment Drug Product Portfolio
  96. 6.16.5 Merck KGaA Recent Developments
  97. 6.17 Novartis
  98. 6.17.1 Novartis Company Information
  99. 6.17.2 Novartis Business Overview
  100. 6.17.3 Novartis Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Novartis Tumor Treatment Drug Product Portfolio
  102. 6.17.5 Novartis Recent Developments
  103. 6.18 Johnson & Johnson
  104. 6.18.1 Johnson & Johnson Company Information
  105. 6.18.2 Johnson & Johnson Business Overview
  106. 6.18.3 Johnson & Johnson Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Johnson & Johnson Tumor Treatment Drug Product Portfolio
  108. 6.18.5 Johnson & Johnson Recent Developments
  109. 6.19 Sanofi
  110. 6.19.1 Sanofi Company Information
  111. 6.19.2 Sanofi Business Overview
  112. 6.19.3 Sanofi Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Sanofi Tumor Treatment Drug Product Portfolio
  114. 6.19.5 Sanofi Recent Developments
  115. 6.20 Teva
  116. 6.20.1 Teva Company Information
  117. 6.20.2 Teva Business Overview
  118. 6.20.3 Teva Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Teva Tumor Treatment Drug Product Portfolio
  120. 6.20.5 Teva Recent Developments
  121. 6.21 Eisai
  122. 6.21.1 Eisai Company Information
  123. 6.21.2 Eisai Business Overview
  124. 6.21.3 Eisai Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 Eisai Tumor Treatment Drug Product Portfolio
  126. 6.21.5 Eisai Recent Developments
  127. 6.22 Takeda
  128. 6.22.1 Takeda Company Information
  129. 6.22.2 Takeda Business Overview
  130. 6.22.3 Takeda Tumor Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 Takeda Tumor Treatment Drug Product Portfolio
  132. 6.22.5 Takeda Recent Developments
7 North America
  1. 7.1 North America Tumor Treatment Drug Market Size (2021-2032)
  2. 7.2 North America Tumor Treatment Drug Market Size by Type
  3. 7.2.1 North America Tumor Treatment Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America Tumor Treatment Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America Tumor Treatment Drug Market Share by Type (2021-2032)
  6. 7.3 North America Tumor Treatment Drug Market Size by Application
  7. 7.3.1 North America Tumor Treatment Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America Tumor Treatment Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America Tumor Treatment Drug Market Share by Application (2021-2032)
  10. 7.4 North America Tumor Treatment Drug Market Size by Country
  11. 7.4.1 North America Tumor Treatment Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Tumor Treatment Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America Tumor Treatment Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America Tumor Treatment Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Tumor Treatment Drug Market Size (2021-2032)
  2. 8.2 Europe Tumor Treatment Drug Market Size by Type
  3. 8.2.1 Europe Tumor Treatment Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe Tumor Treatment Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe Tumor Treatment Drug Market Share by Type (2021-2032)
  6. 8.3 Europe Tumor Treatment Drug Market Size by Application
  7. 8.3.1 Europe Tumor Treatment Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe Tumor Treatment Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe Tumor Treatment Drug Market Share by Application (2021-2032)
  10. 8.4 Europe Tumor Treatment Drug Market Size by Country
  11. 8.4.1 Europe Tumor Treatment Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Tumor Treatment Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe Tumor Treatment Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe Tumor Treatment Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Tumor Treatment Drug Market Size (2021-2032)
  2. 9.2 China Tumor Treatment Drug Market Size by Type
  3. 9.2.1 China Tumor Treatment Drug Market Size by Type (2021-2026)
  4. 9.2.2 China Tumor Treatment Drug Market Size by Type (2027-2032)
  5. 9.2.3 China Tumor Treatment Drug Market Share by Type (2021-2032)
  6. 9.3 China Tumor Treatment Drug Market Size by Application
  7. 9.3.1 China Tumor Treatment Drug Market Size by Application (2021-2026)
  8. 9.3.2 China Tumor Treatment Drug Market Size by Application (2027-2032)
  9. 9.3.3 China Tumor Treatment Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Tumor Treatment Drug Market Size (2021-2032)
  2. 10.2 Asia Tumor Treatment Drug Market Size by Type
  3. 10.2.1 Asia Tumor Treatment Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia Tumor Treatment Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia Tumor Treatment Drug Market Share by Type (2021-2032)
  6. 10.3 Asia Tumor Treatment Drug Market Size by Application
  7. 10.3.1 Asia Tumor Treatment Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia Tumor Treatment Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia Tumor Treatment Drug Market Share by Application (2021-2032)
  10. 10.4 Asia Tumor Treatment Drug Market Size by Country
  11. 10.4.1 Asia Tumor Treatment Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Tumor Treatment Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia Tumor Treatment Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia Tumor Treatment Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Tumor Treatment Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Tumor Treatment Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Tumor Treatment Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Tumor Treatment Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Tumor Treatment Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Tumor Treatment Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Tumor Treatment Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Tumor Treatment Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Tumor Treatment Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Tumor Treatment Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Tumor Treatment Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Tumor Treatment Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Tumor Treatment Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Tumor Treatment Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst